| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |